Cytomegalovirus Infection and Cryptococcal Infection in Patient with Immunosuppression with Myasthenia Gravis
NEJM 395:804-815, Ankomah,P.O.,et al, 2026
Accuracy of Antibody Testing in Myasthenia Gravis
Neurol 107:e218301, Giannoccaro,M.P.,et al, 2026
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis, The PREVAIL Phase 3 Randomized Clinical Trial
JAMA Neurol 83:841-850, Gwathmey,K.G.,et al, 2026
Dysphagia as the Sole Manisfestation of Myasthenia Gravis
JNNP 76:1297-1300, Llabrs,M.,et al, 2005
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Acetylcholine Receptor Antibodies in Juvenile Myasthenia Gravis
Neurol 43:977-982, Andrews,P.I.,et al, 1993
Seronegative Generalized Myasthenia Gravis:Low Frequency of Thymic Pathology
Neurol 42:586-589, Verma,P.K.&Oger,J-F., 1992
Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991
Seronegative Myasthenia Gravis
Neurol 38:514-517, Soliven,B.C.,et al, 1988
Myasthenia Gravis without Acetylcholine-Receptor Antibody:A Distinct Disease Entity
Lancet 1:116-118, Mossman,S.,et al, 1986
Serum Antibodies to Cytomegalovirus in Myasthenia Gravis:Effects of Thymectomy & Steroids
Neurol 28:273, Tindall,R.S.A.,et al, 1978